Translational research brings new findings from bench to bedside to expedite improvement in patient outcomes. Baylor Scott & White Research Institute (BSWRI) also brings these findings to lecture halls and conferences to ensure postgraduates are well-informed of the latest findings and “best clinical practices” in their disease specialty.
In July 2021, Baylor Scott & White Health (BSWH) launched the Nursing Institute, a system-wide endeavor to elevate the nursing profession by strengthening research, continuing education, and professional excellence. In partnership with Baylor Scott & White Research Institute (BSWRI), the Nursing Institute is driving critical research to improve the practice of nursing and overall administering of care in the hospital environment.
Editorial by Todd Grazia, MD, Chief of Transplant Pulmonology, Baylor University Medical Center
When SARS Co-V2 arrived on U.S. shores in early 2020, physicians in all specialties faced an enormous learning curve. As many have said, we didn’t know what we didn’t know about the coronavirus. Some patients seemed to skate through the infection, while others were laid up with flu-like symptoms for a few weeks, and yet others developed severe respiratory failure from ARDS and died. Pulmonologists and intensivists were tasked with caring for and trying to treat a critical patient population whose lungs seemed to be systematically attacked, and often, permanently damaged by the virus. As the pandemic continued to rage and upend lives, transplant pulmonologists faced a daunting ethical dilemma: Should we or should we not consider lung transplantation for patients with irreversible lung damage from COVID-19?
An estimated 3 million individuals in the U.S. live with a condition called atrial fibrillation, or AFib, with some estimates projecting that number being closer to 6 million when taking unknown and undiagnosed cases into account.
Baylor Scott & White Research Institute (BSWRI) is well known for its diverse research portfolio. The program actively maintains nearly 2,000 active and enrolling projects across more than 50 medical specialties each year, including initiatives supported by its translational research program. The program is focused on driving innovation by working with clinical teams across the Baylor Scott & White Health System to develop new medicines and diagnostic tests. The translational research team’s approach to discovery of “bench-to-bedside- and- back-to-bench” allows BSWRI to continue to be a major contributor to advancements in medical science.
